Market research of medicinal products which are used in cardiological diseases treatment

Authors

  • O. S. Kukhtenko National University of Pharmacy, Kharkiv, Ukraine,
  • L. S. Simonyan National University of Pharmacy, Kharkiv, Ukraine,
  • Ye. V. Hladukh National University of Pharmacy, Kharkiv, Ukraine,

DOI:

https://doi.org/10.14739/2409-2932.2017.2.103783

Keywords:

cardiac disease, neurotic disorders, drug combinations, plant extracts

Abstract

Aim of the study is to carry out market research of medicinal products which are used in cardiological diseases treatment.

Materials and methods. The products range analysis was performed according to the Ukraine State Register of medicines and classification system of ATC. We have studied the pharmaceutical market of cardiotonic action drugs (С01 – cardiological medicines, namely C01ЕВ – other cardiological drugs and С01ЕХ – various combined cardiological drugs). It has been determined that the market of cardiological action preparations is characterized by favorable environment for implementation of the new offered product from the point of view of drugs’ economic affordability to consumers. Manufacture leaders of this group of preparations of foreign and domestic production have been denoted.

Results of the study. The ratio of medicines trade names of foreign and domestic production is 35 % to 65 %, full dominance of domestic medicines is observed. In the period from 2012 to 2016 the supply of domestic products had increased by 37.6 %, and foreign by 18.6 %. Analysis of registered trade names of medicines by manufacturing companies has shown that the main share of the assortment is formed by drugs of European pharmaceutical companies.

Conclusions. Тhe development of domestic production of cardiac funds is a positive factor for the development of drugs in this market segment and it indicates the widespread use of this category of drugs among the population of the country. The analysis of dosage forms was conducted, according to which tablets and liquid dosage forms of a combination composition – tinctures and drops – are the most popular among consumers.

References

Kuhtenko, O. S., & Нladukh, E. V. (2014) Aktualnist rozrobky preparativ kardiotonichnoi dii na osnovi roslynnoi syrovyny [Actuality developing drugs cardiotonic action based on vegetable raw materials]. Farmakoekonomika v Ukraini: stan ta perspektyvy rozvytku. Proceedings of the VII Scientific and Practical Conference. (P. 133–134). Kharkiv. [in Ukrainian].

Yevropeiska baza danykh statystychnoi informatsii «Zdorov’ia dlia vsikh» [The European statistic information database "Health for All"]. Retrieved from http://medstat.gov.ua/ukr/normdoc.html. [in Ukrainian].

Mnushko, Z. N., & Trufan, S. B. (2002) Farmakoe´konomicheskaya ocenka gipolipidemicheskikh lekarstvennykh preparatov [Farmakoeconomics evaluation of lipid-lowering drugs]. Provizor, 21, 18–25. [in Russian].

Nemchenko, A. S., & Halii, L. V. (2001) Farmakoekonomika: metodyka provedennia monitorinhu tsin ta vyznachennia rivnia dostupnosti tsin na medykamenty v Ukraini [Pharmacoeconomics, pricing methodology for monitoring and determining the level of access prices for medicines in Ukraine]. Liky Ukrainy, 5, 17–19. [in Ukrainian].

Kompendium - lekarstvennye preparaty [Compendium - Drugs]. Retrieved from http://compendium.com.ua/.

Derzhavnyi reiestr likarskykh zasobiv Ukrain [State register of medicines Ukraine]. Retrieved from http://www.drlz.kiev.ua/

Downloads

How to Cite

1.
Kukhtenko OS, Simonyan LS, Hladukh YV. Market research of medicinal products which are used in cardiological diseases treatment. Current issues in pharmacy and medicine: science and practice [Internet]. 2017Jun.21 [cited 2024Dec.27];(2). Available from: http://pharmed.zsmu.edu.ua/article/view/103783

Issue

No. 2 (2017)

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.     Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)